Cargando…

194. Progression of an Uncomplicated Urinary Tract Infection Among Female Patients with Susceptible and Non-Susceptible Urine Isolates: Findings from an Integrated Delivery Network

BACKGROUND: Uncomplicated urinary tract infection (uUTI) is often treated empirically without antibiotic (AB) susceptibility testing; however, antimicrobial-resistant bacteria could lead to suboptimal treatment and progression to complicated UTI (cUTI). We examined the likelihood of uUTI progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafrin, Jason, Marijam, Alen, Joshi, Ashish V, Mitrani-Gold, Fanny S, Everson, Katie, Tuly, Rifat, Rosenquist, Peter, Gillam, Michael, Ruiz, Maria Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Oral Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643775/ http://dx.doi.org/10.1093/ofid/ofab466.194

Ejemplares similares

Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network database
por: Shafrin, Jason, et al.
Publicado: (2022)

Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health records
por: Shafrin, Jason, et al.
Publicado: (2022)

196. Activity Impairment and Health-Related Quality of Life Associated with an Uncomplicated Urinary Tract Infection Among US Females
por: Thompson, Jeffrey, et al.
Publicado: (2021)

197. Healthcare Resource Utilization and Costs Associated with Inappropriate and Suboptimal Prescribing of Antibiotics for Uncomplicated Urinary Tract Infection in the United States
por: Moon, Rena, et al.
Publicado: (2021)

1415. Allergies to Antimicrobial Agents Among US Females with Uncomplicated Urinary Tract Infection
por: Thompson, Jeffrey, et al.
Publicado: (2021)

1227. A Survey Study of Healthcare Resource Use, and Direct and Indirect Costs, Among Females with an Uncomplicated Urinary Tract Infection in the United States
por: Thompson, Jeffrey, et al.
Publicado: (2021)

Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United States
por: Thompson, Jeffrey, et al.
Publicado: (2023)

Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician survey
por: O’Brien, Megan, et al.
Publicado: (2023)

1434. Treatment Patterns, Healthcare Resource Use, and Associated Costs in Females with Uncomplicated Urinary Tract Infection in the United States
por: Moon, Rena, et al.
Publicado: (2021)

1429. Real-World Study of Patients with Uncomplicated Urinary Tract Infection in the United States: High-Risk Comorbid Conditions and Burden of Illness
por: Preib, Madison T, et al.
Publicado: (2021)

Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States
por: Moon, Rena C., et al.
Publicado: (2022)

123. Treatment Patterns and Prevalence of Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the US
por: Wang, Yuexi, et al.
Publicado: (2020)

1414. Real-World Study of Healthcare Resource Use and Costs Associated with Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the United States
por: Preib, Madison T, et al.
Publicado: (2021)

P19 Burden of illness and costs among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

1358. A Real-World Study of the Burden of Illness and Treatment Patterns Among Patients with Uncomplicated Urogenital Gonorrhea in the United States
por: Preib, Madison T, et al.
Publicado: (2021)

2839. Cost Burden of Patients with Oral Antibiotic Treatment Failure for Uncomplicated Urinary Tract Infection in the United States
por: Franklin, Meg, et al.
Publicado: (2023)

P18 Treatment patterns and extent of inappropriate antimicrobial treatment among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

P17 Baseline characteristics, disease progression rates and risk factors among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

2840. Prevalence of Acute Uncomplicated Cystitis in Japan
por: Franklin, Meg, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis to Estimate the Treatment Effect and Inform a Noninferiority Margin for a Phase 3 Noninferiority Trial in Uncomplicated Urogenital Gonorrhea
por: Mitrani-Gold, Fanny S., et al.
Publicado: (2022)

2838. Clinical Application and Validation of a Predictive Antimicrobial Resistance Risk Categorization Framework for Patients with Uncomplicated Urinary Tract Infection
por: Shields, Ryan K, et al.
Publicado: (2023)

17. Comparative Safety of Antibiotic Therapy for Outpatient Treatment of Uncomplicated Urinary Tract Infections
por: Butler, Anne M, et al.
Publicado: (2020)

2225. Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

2226. Analysis of Co-Resistance Among Klebsiella pneumoniae Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

187. Regional Distribution of Antimicrobial Resistance Among Outpatient Urine e. Coli Isolates in US Females ≥12 Years of age: a Multicenter Evaluation in 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

1698. Trends in antimicrobial resistance among outpatient urine E. coli isolates in US females ≥12 years of age: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

P194 Disseminated fusariosis in h ematological malignancies with favo rable outcomes
por: Fernandez, Norma B., et al.
Publicado: (2022)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

1512. Variation in Outpatient Urine Testing Practices for Uncomplicated Urinary Tract Infections
por: Liu, Sonya, et al.
Publicado: (2018)

The cost bloodstream infections caused by antimicrobial susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals
por: Stewardson, AJ, et al.
Publicado: (2015)

1032 Microbiologically-evaluable Complicated Urinary Tract Infection: Characterization in an Observational Data Source
por: Mundy, Linda, et al.
Publicado: (2014)

182. Back to The Future: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children
por: McNeil, Jonathon C, et al.
Publicado: (2021)

186. A Systematic Literature Review on the Economic Burden of Illness in Gonorrhea
por: Martin, Amber, et al.
Publicado: (2020)

P377 Study of the prevalence of candidemia and its antifungal susceptibility pattern in a tertiary care hospital
por: Sharma, Alisha, et al.
Publicado: (2022)

P089 Candidemia: prevalence, species characterization ,and the antibiotic susceptibility profile from a tertiary care hospital in north india
por: William, Ashish, et al.
Publicado: (2022)

Uncomplicated Urinary Tract Infections in Women in a Sao Paulo Quaternary Care Hospital: Bacterial Spectrum and Susceptibility Patterns
por: Hisano, Marcelo, et al.
Publicado: (2014)

Identification of clinical and urine biomarkers for uncomplicated urinary tract infection using machine learning algorithms
por: Gadalla, Amal A. H., et al.
Publicado: (2019)

The Role of Urinary Nitrite in Predicting Bacterial Resistance in Urine Culture Analysis Among Patients With Uncomplicated Urinary Tract Infection
por: Papava, Vladimer, et al.
Publicado: (2022)

Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon A, et al.
Publicado: (2023)

S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY
por: Offner, Fritz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b1nj5ch45c8sit9hdti8092dct